Janus Henderson Investors US’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$252M Sell
3,880,284
-4,653,720
-55% -$293M 0.21% 135
2016
Q4
$534M Sell
8,534,004
-6,275,751
-42% -$383M 0.45% 45
2016
Q3
$934M Sell
14,809,755
-6,764,730
-31% -$438M 0.79% 18
2016
Q2
$1.34B Sell
21,574,485
-3,830,302
-15% -$233M 1.13% 9
2016
Q1
$1.45B Sell
25,404,787
-1,396,049
-5% -$77.8M 1.26% 8
2015
Q4
$1.59B Buy
26,800,836
+2,959,610
+12% +$170M 1.35% 7
2015
Q3
$1.3B Buy
23,841,226
+482,235
+2% +$31.4M 1.16% 8
2015
Q2
$1.57B Buy
23,358,991
+3,701,343
+19% +$242M 1.29% 5
2015
Q1
$1.15B Buy
19,657,648
+4,883,597
+33% +$295M 0.95% 13
2014
Q4
$967M Sell
14,774,051
-2,801,894
-16% -$177M 0.83% 15
2014
Q3
$1.02B Buy
17,575,945
+485,048
+3% +$26.9M 0.93% 12
2014
Q2
$965M Sell
17,090,897
-1,594,598
-9% -$83.7M 0.88% 16
2014
Q1
$960M Sell
18,685,495
-1,788,896
-9% -$90.4M 0.89% 16
2013
Q4
$1.08B Sell
20,474,391
-3,702,514
-15% -$182M 1.02% 10
2013
Q3
$1.08B Buy
24,176,905
+2,341,514
+11% +$104M 1.07% 9
2013
Q2
$903M Buy
+21,835,391
New +$955M 0.94% 16

Other funds holding ABBV

Janus Henderson Investors US's ABBV Position: Q1 2017 in Review

Janus Henderson Investors US reduced its AbbVie (ABBV) stake by 55% in Q1 2017, selling an estimated $293M and leaving 3,880,284 shares worth $252M. The position accounts for 0.21% of the portfolio, ranked #135.

Janus Henderson Investors US first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.59B in Q4 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Janus Henderson Investors US held 3,880,284 shares of AbbVie worth $252M as of Q1 2017.
  • Janus Henderson Investors US sold 4,653,720 AbbVie shares in Q1 2017, an estimated $293M.
  • AbbVie made up 0.21% of Janus Henderson Investors US's portfolio in Q1 2017, its #135 holding.
  • Janus Henderson Investors US first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's AbbVie position peaked at $1.59B in Q4 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.